LOVE & HEALTH LIMITED
NOTES TO FINANCIAL STATEMENTS
NOTE 4 – PRIVATE PLACEMENT
The Sponsor will agree to purchase an aggregate of 257,500 private units (or 272,500 if the underwriters’ over-allotment is exercised in full) at $10.00 per Private Unit (for a total purchase price of $2,575,000 or $2,762,500 in the aggregate if the underwriters’ over-allotment is exercised in full), in each case, in a private placement that will occur simultaneously with the closing of the Proposed Public Offering. Each Private Unit consists of one Private Placement Share and one right (“Private Placement Right”).
The Private Units are identical to the units to be sold in the Proposed Public Offering except with respect to certain registration rights and transfer restrictions.
NOTE 5 – RELATED PARTY TRANSACTIONS
Founder Shares
On October 25, 2023, the Company issued an aggregate of 1,437,500 founder shares to the initial shareholder, including an aggregate of 187,500 Class B ordinary shares subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment option is not exercised in full or in part, so that the initial shareholder will collectively own 20% of the issued and outstanding shares after the Proposed Public Offering (excluding the sale of the Private Units and assuming the initial shareholders do not purchase any Units in the Proposed Public Offering) (see Note 6) for an aggregate purchase price of $25,000.
The founder shares are Class B ordinary shares that automatically convert into Class A ordinary shares at the time of an initial business combination, or at any time prior thereto at the option of the holder, on a one-for-one basis, subject to adjustment pursuant to certain anti-dilution rights, as described herein, for no additional consideration.
Promissory Note — Related Party
On October 25, 2023, the Company issued an unsecured promissory note to the Sponsor, pursuant to which the Company may borrow up to an aggregate principal amount of $500,000 (the “Promissory Note”). The Promissory Note is non-interest bearing and payable on the earlier of June 30, 2024 or consummation of an initial public offering of the Company’s securities.
As of October 25, 2023, the Sponsor advanced the Company an aggregate amount of $61,625.
Administrative Services Arrangement
An affiliate of the Sponsor agreed that, commencing from the date that the Company’s securities are first listed on NASDAQ through the earlier of the Company’s consummation of a Business Combination and its liquidation, to make available to the Company certain general and administrative services, including office space, administrative and support services, as the Company may require from time to time. The Company has agreed to pay the affiliate of the Sponsor $10,000 per month for these services commencing on the closing date of the Initial Public Offering for 12 months (or up to 36 months if the Company extends the Combination Period).
NOTE 6 – SHAREHOLDER’S EQUITY
Preferred shares
The Company is authorized to issue 1,000,000 preferred shares at par value of $0.0001. As of October 25, 2023, no preferred share was issued and outstanding.
Ordinary shares
The Company is authorized to issue 100,000,000 Class A ordinary shares at par value of $0.0001. Holders of the Company’s ordinary shares are entitled to one vote for each share. On October 3, 2023, the Company issued 50,000 ordinary shares of a par value $1.00 each to the Sponsor. On October 25, 2023, the 50,000 ordinary shares subdivided into 500,000,000 Class A ordinary shares of par value $0.0001 each. On October 25, 2023, the 500,000,000 Class A ordinary shares were repurchased and then the 400,000,000 Class A ordinary shares were retired. As of October 25, 2023, no Class A ordinary share was issued and outstanding.